Classification of myositis

224th ENMC International Workshop:

(2018) Yves Allenbach et al.   NEUROMUSCULAR DISORDERS

Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis

(2017) Siamak Moghadam-Kia et al.   JOURNAL OF RHEUMATOLOGY

Integrated classification of inflammatory myopathies

(2017) Y. Allenbach et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients

(2017) Anna Rogers et al.   ARTHRITIS CARE & RESEARCH

Skeletal Muscle Involvement in Antisynthetase Syndrome

(2017) Eri Noguchi et al.   JAMA Neurology

2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups

(2017) Ingrid E. Lundberg et al.   Arthritis & Rheumatology

Perifascicular necrosis in anti-synthetase syndrome beyond anti-Jo-1

(2016) Akinori Uruha et al.   BRAIN

The reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) among dermatologists, rheumatologists and neurologists

(2016) J. Tiao et al.   BRITISH JOURNAL OF DERMATOLOGY

Clinical signs associated with an increased risk of interstitial lung disease: a retrospective study of 101 patients with dermatomyositis

(2016) C.C. Ang et al.   BRITISH JOURNAL OF DERMATOLOGY

Spectrum of immune-mediated necrotizing myopathies and their treatments

(2016) Iago Pinal-Fernandez et al.   CURRENT OPINION IN RHEUMATOLOGY

Recent advances in dermatomyositis-specific autoantibodies

(2016) Manabu Fujimoto et al.   CURRENT OPINION IN RHEUMATOLOGY

Diagnosis and classification of idiopathic inflammatory myopathies

(2016) I. E. Lundberg et al.   JOURNAL OF INTERNAL MEDICINE

Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group

(2016) Ernesto Trallero-Araguás et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis

(2015) Lénaig Mescam-Mancini et al.   BRAIN

Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical change

(2015) C.O. Anyanwu et al.   BRITISH JOURNAL OF DERMATOLOGY

Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features—a Comprehensive Review

(2015) Yoshinao Muro et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Myositis-specific autoantibodies: an important tool to support diagnosis of myositis

(2015) Z. Betteridge et al.   JOURNAL OF INTERNAL MEDICINE

The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis

(2015) I. Pinal-Fernandez et al.   JOURNAL OF RHEUMATOLOGY

Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis

(2015) David F. Fiorentino et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy

(2015) W. Stenzel et al.   NEUROLOGY

Improvement in the cutaneous disease activity of patients with dermatomyositis is associated with a better quality of life

(2014) E.S. Robinson et al.   BRITISH JOURNAL OF DERMATOLOGY

Long-term follow-up of 62 patients with myositis

(2014) Janneke van de Vlekkert et al.   JOURNAL OF NEUROLOGY

Evaluation and construction of diagnostic criteria for inclusion body myositis

(2014) T. E. Lloyd et al.   NEUROLOGY

Ongoing Developments in Sporadic Inclusion Body Myositis

(2014) Pedro M. Machado et al.   Current Rheumatology Reports

Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy

(2014) Jessie Aouizerate et al.   Acta Neuropathologica Communications

Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features

(2013) Stefen Brady et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

188th ENMC International Workshop: Inclusion Body Myositis, 2–4 December 2011, Naarden, The Netherlands

(2013) M.R. Rose   NEUROMUSCULAR DISORDERS

Evaluation of Reliability, Validity, and Responsiveness of the CDASI and the CAT-BM

(2012) Renato Goreshi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Review: Immune-mediated necrotizing myopathies - a heterogeneous group of diseases with specific myopathological features

(2012) W. Stenzel et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Clinical Correlations With Dermatomyositis-Specific Autoantibodies in Adult Japanese Patients With Dermatomyositis

(2011) Yasuhito Hamaguchi et al.   ARCHIVES OF DERMATOLOGY

Autoantibodies to transcription intermediary factor 1 in dermatomyositis shed insight into the cancer-myositis connection

(2011) David Fiorentino et al.   ARTHRITIS AND RHEUMATISM

Acquired immune and inflammatory myopathies

(2011) Alan Pestronk   CURRENT OPINION IN RHEUMATOLOGY

The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study

(2011) David Fiorentino et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Modification of the Cutaneous Dermatomyositis Disease Area and Severity Index, an outcome instrument

(2009) M. Yassaee et al.   BRITISH JOURNAL OF DERMATOLOGY

Clinical Differences Between Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis and Classic Dermatomyositis

(2009) Hiroshi Mukae et al.   CHEST

Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis

(2008) R.Q. Klein et al.   BRITISH JOURNAL OF DERMATOLOGY